ADMA Biologics
ADMA
13.17
-0.17
-1.27%
ADMA Biologics
US · ADMA
#2705 by market cap
Listed 1970
13.17
-0.17
-1.27%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About ADMA Biologics
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
- Founded
- 2004
- CEO
- Mr. Adam S. Grossman
- Employees
- 647
- Headquarters
- Ramsey, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- admabiologics.com
Company profile
- Exchange
- US
- Symbol
- ADMA
- Market-cap rank
- #2705
- Listing date
- 1970-01-01
- Market cap
- 2.92B
- Float cap
- 2.70B
- Shares out
- 221.85M
- Float shares
- 205.22M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
ADMA Biologics discussion 0 comments